NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · USA
Perrigo Company plc is a mid cap company (market value between $2 billion and $10 billion) in the Drug Manufacturers - Specialty & Generic industry.
Perrigo Company plc manufactures and sells over-the-counter self-care products across two geographic segments. Consumer Self-Care Americas provides both retailer-branded and company-owned products to major chains in North America. Consumer Self-Care International markets branded products in Europe and Australia. The company's portfolio spans upper respiratory, digestive health, pain relief, oral care, skin care, women's health, and vitamins.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Perrigo Company plc stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: a figure this valuation depends on is missing.
Leak Score: 18/100 on 9 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 84 Drug Manufacturers - Specialty & Generic stocks
34 more in this industry show a wider margin of safety.
We do not publish a verdict on PRGO yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-10-19 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
18 out of 100, which we rate "On Watch", on 9 of 12 value investing signals.